ANTIPODES PARTNERS Ltd Has $89.86 Million Holdings in Nutrien Ltd. (NYSE:NTR)

ANTIPODES PARTNERS Ltd grew its holdings in Nutrien Ltd. (NYSE:NTR - Free Report) by 18,312.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,595,295 shares of the company's stock after purchasing an additional 1,586,631 shares during the quarter. Nutrien comprises 2.8% of ANTIPODES PARTNERS Ltd's portfolio, making the stock its 17th biggest holding. ANTIPODES PARTNERS Ltd owned approximately 0.32% of Nutrien worth $89,862,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its position in shares of Nutrien by 1.9% in the third quarter. Vanguard Group Inc. now owns 18,052,214 shares of the company's stock valued at $1,114,905,000 after purchasing an additional 332,190 shares during the last quarter. Deutsche Bank AG grew its position in Nutrien by 1.5% during the third quarter. Deutsche Bank AG now owns 14,708,135 shares of the company's stock worth $908,374,000 after buying an additional 214,299 shares in the last quarter. Mackenzie Financial Corp grew its position in Nutrien by 2.2% during the third quarter. Mackenzie Financial Corp now owns 13,091,872 shares of the company's stock worth $748,638,000 after buying an additional 282,531 shares in the last quarter. Parnassus Investments LLC grew its position in Nutrien by 1.3% during the third quarter. Parnassus Investments LLC now owns 10,057,019 shares of the company's stock worth $621,121,000 after buying an additional 131,418 shares in the last quarter. Finally, First Eagle Investment Management LLC grew its position in Nutrien by 0.5% during the third quarter. First Eagle Investment Management LLC now owns 9,262,659 shares of the company's stock worth $572,062,000 after buying an additional 48,230 shares in the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Trading Up 1.0 %

NTR stock traded up $0.55 during trading on Friday, hitting $56.74. The company had a trading volume of 2,053,408 shares, compared to its average volume of 2,084,259. The company has a quick ratio of 0.65, a current ratio of 1.17 and a debt-to-equity ratio of 0.35. The firm has a 50-day moving average price of $52.22 and a 200-day moving average price of $54.95. Nutrien Ltd. has a 12 month low of $47.90 and a 12 month high of $75.29. The stock has a market cap of $28.06 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 1.82 and a beta of 0.89.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 21st. The company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.72 by ($0.35). Nutrien had a return on equity of 8.59% and a net margin of 4.33%. The company had revenue of $5.66 billion during the quarter, compared to the consensus estimate of $5.36 billion. During the same quarter last year, the firm earned $2.02 EPS. The business's revenue for the quarter was down 24.8% on a year-over-year basis. As a group, analysts predict that Nutrien Ltd. will post 3.86 earnings per share for the current year.

Nutrien Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 11th. Investors of record on Thursday, March 28th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 3.81%. The ex-dividend date of this dividend is Wednesday, March 27th. This is a boost from Nutrien's previous quarterly dividend of $0.53. Nutrien's payout ratio is 85.38%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. CIBC decreased their target price on Nutrien from $87.00 to $76.00 and set an "outperform" rating on the stock in a research report on Friday, February 23rd. Wells Fargo & Company decreased their target price on Nutrien from $77.00 to $69.00 and set an "overweight" rating on the stock in a research report on Monday, February 26th. The Goldman Sachs Group decreased their target price on Nutrien from $88.00 to $78.00 and set a "buy" rating on the stock in a research report on Thursday, February 1st. Jefferies Financial Group started coverage on Nutrien in a research report on Tuesday, March 26th. They set a "buy" rating and a $62.00 target price on the stock. Finally, Raymond James cut shares of Nutrien from an "outperform" rating to a "market perform" rating and cut their price target for the stock from $80.00 to $65.00 in a research note on Friday, January 12th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, Nutrien presently has an average rating of "Moderate Buy" and a consensus target price of $69.43.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.